Achille Bottiglieri

ORCID

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 6

Top Venues

Tumori

Cancer management and research

Future oncology (London, England)

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Caterina Zanella, Alberto Giovanni Leone, Luca Zambelli, Achille Bottiglieri, Luca Canziani, Marta Brambilla, Giuseppe Lo Russo, Marco Platania, Filippo De Braud, Mario Alberto Occhipinti
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series. Tumori 108 (6) (2022)
Emma Zattarin, Sara Manglaviti, Giulia Apollonio, Teresa Beninato, Laura Mazzeo, Giacomo Massa, Achille Bottiglieri, Edoardogregorio Galli, Alessandro De Toma, Mario Occhipinti, Marta Brambilla, Roberto Ferrara, Monica Ganzinelli, Claudia Proto, Marina Chiara Garassino, Filippo de Braud, Giuseppe Lo Russo, Arsela Prelaj
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy. Future oncology (London, England) 18 (23) (2022)
Arsela Prelaj, Mattia Boeri, Alessandro Robuschi, Roberto Ferrara, Claudia Proto, Giuseppe Lo Russo, Giulia Galli, Alessandro De Toma, Marta Brambilla, Mario Occhipinti, Sara Manglaviti, Teresa Beninato, Achille Bottiglieri, Giacomo Massa, Emma Zattarin, Rosaria Gallucci, Edoardo Gregorio Galli, Monica Ganzinelli, Gabriella Sozzi, Filippo G M de Braud, Marina Chiara Garassino, Marcello Restelli, Alessandra Laura Giulia Pedrocchi, Francesco Trovo'
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy. Cancers 14 (2) (2022)
Achille Bottiglieri, Pierangela Sepe, Marco Stellato, Chiara Pircher, Giuseppe Fotia, Alberto Giovanni Leone, Valentina Guadalupi, Melanie Claps, Patrizia Giannatempo, Elena Verzoni, Giuseppe Procopio
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy. Cancer management and research 14 (2022)
Stefano Cavalieri, Elena Colombo, Achille Bottiglieri, Giacomo Massa, Francesca Platini, Arianna Ottini, Daria Maria Filippini, Emma Zattarin, Cristiana Bergamini, Carlo Resteghini, Salvatore Alfieri, Vito Di Martino, Valentina Tiraferri, Laura Deborah Locati, Lisa Licitra
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic. Tumori (2021)
Francesca Ligorio, Luca Zambelli, Achille Bottiglieri, Lorenzo Castagnoli, Emma Zattarin, Riccardo Lobefaro, Arianna Ottini, Andrea Vingiani, Serenella M Pupa, Giulia V Bianchi, Giuseppe Capri, Giancarlo Pruneri, Filippo de Braud
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients. Therapeutic advances in medical oncology 13 (2021)

Achille Bottiglieri.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Achille Bottiglieri